Related Experiment Video
Updated: Aug 2, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Syndromic forms of congenital hyperinsulinism
Martin Zenker1, Klaus Mohnike2, Katja Palm2
1Institute of Human Genetics, University Hospital, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Congenital hyperinsulinism (CHI), or hyperinsulinemic hypoglycemia (HH), is a common cause of infant hypoglycemia. This review explores CHI
Area of Science:
- Endocrinology and Genetics
- Pediatric Metabolism
- Rare Diseases
Background:
- Congenital hyperinsulinism (CHI), also known as hyperinsulinemic hypoglycemia (HH), is a primary cause of persistent hypoglycemia in infants and children.
- While often monogenic, CHI is also linked to various syndromic disorders, including overgrowth syndromes, developmental syndromes, and congenital disorders of glycosylation.
Purpose of the Study:
- To review syndromic conditions associated with CHI.
- To assess the evidence, prevalence, pathophysiology, and natural course of CHI within these syndromes.
Main Methods:
- Literature review of syndromic conditions associated with CHI.
- Assessment of evidence for CHI association, prevalence, pathophysiology, and clinical course.
Main Results:
- CHI is associated with diverse syndromes like Beckwith-Wiedemann, Sotos, Turner, Kabuki, Costello, and Timothy syndromes.
- Mechanisms of dysregulated glucose sensing and insulin secretion in syndromic CHI are often unclear and not linked to known CHI genes.
- The association between syndromes and CHI can be inconsistent, with metabolic disturbances frequently being transient.
Conclusions:
- CHI in syndromic conditions presents diagnostic challenges, especially in newborns with congenital anomalies.
- Early identification of neonatal hypoglycemia is crucial for timely diagnosis and intervention.
- A broad genetic workup may be necessary for infants with HH and associated medical issues.
More Related Videos
08:04Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Insulin Secretory Vesicles